Belysse Group NV (EBR:BELYS)
Belgium
· Delayed Price · Currency is EUR 0.612
-0.028 (-4.38%)
Apr 28, 2026, 10:38 AM CET
Belysse Group NV Revenue
In the year 2025, Belysse Group NV had annual revenue of 254.22M EUR, down -9.33%. Belysse Group NV had revenue of 119.59M in the half year ending December 31, 2025, a decrease of -17.70%.
Revenue
254.22M
Revenue Growth
-9.33%
P/S Ratio
0.09
Revenue / Employee
254.22K
Employees
1,000
Market Cap
22.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 254.22M | -26.16M | -9.33% |
| Dec 31, 2024 | 280.38M | -20.54M | -6.82% |
| Dec 31, 2023 | 300.92M | -36.51M | -10.82% |
| Dec 31, 2022 | 337.43M | 60.62M | 21.90% |
| Dec 31, 2021 | 276.81M | 18.46M | 7.14% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Keyware Technologies NV | 19.93M |
| European Medical Solutions | 52.80M |
| Newtree | 4.76M |
| Banimmo | 7.52M |
| Immo Moury SCA | 3.20M |
| Immo Mechelen City Center Naamloze vennootschap | 2.82M |
| Accentis | 5.78M |
| Celyad Oncology | 21.00K |
Belysse Group NV News
- 6 weeks ago - Belysse Group NV Earnings Call Transcript: H2 2025 - Transcripts
- 8 months ago - Belysse Group NV Earnings Call Transcript: H1 2025 - Transcripts
- 1 year ago - Belysse Group NV Earnings Call Transcript: H2 2024 - Transcripts
- 1 year ago - Belysse Group NV Earnings Call Transcript: H1 2024 - Transcripts